Abstract
Due to recent discoveries of novel genes involved in iron metabolism, our understanding of the molecular mechanisms underlying iron metabolism has dramatically increased. We have previously shown that the administration of angiotensin II alters iron homeostasis in the rat kidney, which may in turn aggravate angiotensin II–induced renal damage. Here we have investigated the effect of angiotensin II administration on the localization and expression of transferrin receptor (TfR), divalent metal transporter 1 (DMT1), ferroportin 1 (FPN), and hepcidin mRNA in the rat kidney. Weak expression of TfR, DMT1, FPN, and hepcidin mRNA was observed in the kidneys of control rats. In contrast, after 7 days of angiotensin II infusion by osmotic minipump, the expression of these mRNAs was more widely distributed. Staining of serial sections revealed that some, but not all, of the renal tubular cells positive for these genes contained iron deposits in the kidney of angiotensin II–infused animals. Real-time polymerase chain reaction (PCR) showed that the mRNA expression of TfR, iron-responsive element–negative DMT1, FPN, and hepcidin mRNA increased ∼1.9-fold, ∼1.7-fold, ∼2.3-fold, and ∼4.7-fold, respectively, after angiotensin II infusion as compared with that of untreated controls, and that these increases could be suppressed by the concomitant administration of losartan. Our data demonstrate that these genes were unequivocally expressed in the kidney and could be regulated by angiotensin II infusion. The relative contribution, if any, of these genes to renal and/or whole-body iron homeostasis in various disorders in which the renin angiotensin system is activated should be investigated in future studies.
Similar content being viewed by others
Article PDF
References
Gunshin H, Mackenzie B, Berger UV, et al: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482–488.
Fleming MD, Trenor CC 3rd, Su MA, et al: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383–386.
Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC : Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 1998; 95: 1148–1153.
McKie AT, Marciani P, Rolfs A, et al: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299–309.
Donovan A, Brownlie A, Zhou Y, et al: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776–781.
Park CH, Valore EV, Waring AJ, Ganz T : Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806–7810.
Nemeth E, Tuttle MS, Powelson J, et al: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090–2093.
Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F : Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005; 106: 3979–3984.
Lu JP, Hayashi K, Awai M : Transferrin receptor expression in normal, iron-deficient and iron-overloaded rats. Acta Pathol Jpn 1989; 39: 759–764.
Ward DT, Hamilton K, Burnand R, Smith CP, Tomlinson DR, Riccardi D : Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney. Biochim Biophys Acta 2005; 1740: 79–84.
Ferguson CJ, Wareing M, Ward DT, Green R, Smith CP, Riccardi D : Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 2001; 280: F803–F814.
Wareing M, Ferguson CJ, Delannoy M, et al: Altered dietary iron intake is a strong modulator of renal DMT1 expression. Am J Physiol Renal Physiol 2003; 285: F1050–F1059.
Chung J, Prohaska JR, Wessling-Resnick M : Ferroportin-1 is not upregulated in copper-deficient mice. J Nutr 2004; 134: 517–521.
Kulaksiz H, Theilig F, Bachmann S, et al: The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005; 184: 361–370.
Ishizaka N, Aizawa T, Yamazaki I, et al: Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest 2002; 82: 87–96.
Saito K, Ishizaka N, Aizawa T, et al: Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II–induced hypertensive rats. Hypertens Res 2004; 27: 599–607.
Saito K, Ishizaka N, Hara M, et al: Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II. Hypertension 2005; 46: 1180–1185.
Aizawa T, Ishizaka N, Taguchi J, et al: Heme oxygenase-1 is upregulated in the kidney of angiotensin II–induced hypertensive rats: possible role in renoprotection. Hypertension 2000; 35: 800–806.
Ishizaka N, Saito K, Mori I, Matsuzaki G, Ohno M, Nagai R : Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II–infused rats. Arterioscler Thromb Vasc Biol 2005; 25: 2282–2288.
Andrews NC : Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 2000; 1: 208–217.
Moura IC, Centelles MN, Arcos-Fajardo M, et al: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417–425.
Moura IC, Arcos-Fajardo M, Gdoura A, et al: Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2667–2676.
Canonne-Hergaux F, Gros P : Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int 2002; 62: 147–156.
Hubert N, Hentze MW : Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 2002; 99: 12345–12350.
Nankivell BJ, Tay YC, Boadle RA, Harris DC : Lysosomal iron accumulation in diabetic nephropathy. Ren Fail 1994; 16: 367–381.
Njajou OT, Vaessen N, Joosse M, et al: A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001; 28: 213–214.
Montosi G, Donovan A, Totaro A, et al: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619–623.
Pietrangelo A : The ferroportin disease. Blood Cells Mol Dis 2004; 32: 131–138.
Corradini E, Montosi G, Ferrara F, et al: Lack of enterocyte iron accumulation in the ferroportin disease. Blood Cells Mol Dis 2005; 35: 315–318.
Ganz T : Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783–788.
Piperno A, Trombini P, Gelosa M, et al: Increased serum ferritin is common in men with essential hypertension. J Hypertens 2002; 20: 1513–1518.
Davis RJ, Corvera S, Czech MP : Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261: 8708–8711.
Kanauchi M, Akai Y, Hashimoto T : Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury. Eur J Intern Med 2002; 13: 190–193.
Zeller A, Haehner T, Battegay E, Martina B : Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure. J Hum Hypertens 2005; 19: 205–209.
Murayama S, Hirano T, Sakaue T, Okada K, Ikejiri R, Adachi M : Low-dose candesartan cilexetil prevents early kidney damage in type 2 diabetic patients with mildly elevated blood pressure. Hypertens Res 2003; 26: 453–458.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ishizaka, N., Saito, K., Furuta, K. et al. Angiotensin II–Induced Regulation of the Expression and Localization of Iron Metabolism–Related Genes in the Rat Kidney. Hypertens Res 30, 195–202 (2007). https://doi.org/10.1291/hypres.30.195
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.30.195
Keywords
This article is cited by
-
Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation
Laboratory Investigation (2017)
-
Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice
European Journal of Nutrition (2015)
-
Angiotensin II Inhibits Iron Uptake and Release in Cultured Neurons
Neurochemical Research (2014)
-
Ovine uterine space restriction alters placental transferrin receptor and fetal iron status during late pregnancy
Pediatric Research (2013)
-
Vision preservation during retinal inflammation by anthocyanin-rich bilberry extract: cellular and molecular mechanism
Laboratory Investigation (2012)
